Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell–mediated antitumor immunity
Michael Wichroski, Joseph L. Benci, Si-Qi Liu, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 719
Closed Access | Times Cited: 11

Showing 11 citing articles:

Exploiting the therapeutic implications of KRAS inhibition on tumor immunity
Mı́riam Molina-Arcas, Julian Downward
Cancer Cell (2024) Vol. 42, Iss. 3, pp. 338-357
Open Access | Times Cited: 46
Photoaffinity labelling with small molecules
Rick A. Homan, John D. Lapek, Christina M. Woo, et al.
Nature Reviews Methods Primers (2024) Vol. 4, Iss. 1
Closed Access | Times Cited: 10
A functional single-cell metabolic survey identifies Elovl1 as a target to enhance CD8+ T cell fitness in solid tumours
Samantha Pretto, Qian Yu, Pierre Bourdely, et al.
Nature Metabolism (2025)
Open Access | Times Cited: 1
Diacylglycerol kinase zeta dictates CD40-mediated immune synapse formation, mTORC1 signaling and plasma cell fate in B lymphocytes
Ana Fernández-Barrecheguren, Adrián Fernández-Rego, Lucía Fuentes-Cantos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Spatial genomics reveals cholesterol metabolism as a key factor in colorectal cancer immunotherapy resistance
Andrew J. Kavran, Yulong Bai, Brian Rabe, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Discovery of Potent, Dual-Inhibitors of Diacylglycerol Kinases Alpha and Zeta Guided by Phenotypic Optimization
Louis S. Chupak, Michael Wichroski, Xiaofan Zheng, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 7, pp. 929-935
Closed Access | Times Cited: 7
Applications of Flow Cytometry in Drug Discovery and Translational Research
Sumana Ullas, Charles Sinclair
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3851-3851
Open Access | Times Cited: 2
Ligand discovery by activity-based protein profiling
Micah J. Niphakis, Benjamin F. Cravatt
Cell chemical biology (2024) Vol. 31, Iss. 9, pp. 1636-1651
Closed Access | Times Cited: 2
Pharmacological inhibition of HPK1 synergizes with PD-L1 blockade to provoke antitumor immunity against tumors with low antigenicity
Genzui Setsu, Megumi Goto, Kentaro Ito, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 715, pp. 149995-149995
Closed Access | Times Cited: 1
Diacylglycerol kinases: A look into the future of immunotherapy
Miguel Martin-Salgado, Ane Ochoa-Echeverría, Isabel Mérida
Advances in Biological Regulation (2023) Vol. 91, pp. 100999-100999
Open Access | Times Cited: 3
Diacylglycerol Kinases and Its Role in Lipid Metabolism and Related Diseases
Yi‐Shi Liu, Zehui Yang, Xiaoman Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13207-13207
Open Access
Page 1

Scroll to top